MRNA vs PVLA · rev $145.0M vs $1.64B cap
Moderna Inc (MRNA) versus Palvella Therapeutics, Inc (PVLA) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Palvella Therapeutics, Inc (PVLA) is a biotechnology company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
PVLA does not have a complete income-statement cache yet.
MRNA currently screens at market cap $24.52B. PVLA currently screens at market cap $1.64B.
Not investment advice. Open the MRNA and PVLA stock pages for the full models.
Not investment advice.